CPHI Worldwide: book a meeting with Alfasigma Contract Manufacturing

Alfasigma: flexibility, innovation and leading edge technologies.

CDMO sector is playing an increasingly strategic role in drug development and delivery for pharmaceutical companies and Alfasigma Contract Manufacturing has been gearing up to meet evolving customer needs for innovation, flexibility, latest generation technologies and impeccable quality.

After years of expansion that saw the acquisition of new production lines in Pomezia for a footprint of more than 400 square meters, the company has just opened a new sterile department on its Alanno site and before the end of the year will open another sterile facility, ensuring maximum flexibility in formats. Alanno covers a total of 100,000 square meters.

More than 2,800 employees and a worldwide presence in more than 90 countries, Alfasigma is convinced of the crucial importance in working closely with customers through all stages of product development, offering agility, speed and innovation to reduce time to market.

Alfasigma produces a vast range of formulations and formats ranging from sterile powders to granules, capsules, semisolids and injection solutions. Its adherence to the highest quality standards is demonstrated by a long list of certifications, including FDA, ANVISA, GCC, PMDA and EUGMP.

To discover first-hand the unique advantages of partnering with Alfasigma, we invite you to arrange a meeting at our stand at CPHI in Frankfurt (November 5-7). In a comfortable surroundings of our stand, you will be able to hear directly from our experts how Alfasigma can support your business.